« Back to members

Manchester Science Partnerships

Manchester Science Partnerships


member image

Manchester Science Partnerships (MSP) is a Manchester based public-private partnership and the UK's leading science and technology park operator. MSP owns and operates 2m sq ft of office and laboratory space on its three main campuses – Manchester Science Park, Citylabs, and Alderley Park.

MSP provides the right environments for innovation to flourish - supporting the growth of companies in the life sciences, digital technology and advanced engineering sectors, ranging in size from start-ups to European HQs and international centres of R&D excellence.


 Its network of innovators, scientists, investors and entrepreneurs enables businesses and people to transform ideas into commercial reality.


 MSP's shareholders are Bruntwood Ltd, The University of Manchester, Manchester Metropolitan University, Manchester University NHS Foundation Trust (MFT) and Manchester, Cheshire East and Salford City Councils.


 Opened in September 2017, MSP’s 70,000 sq ft Bright Building is located in the heart of Manchester Science Park and is part of the Oxford Road Corridor Innovation District. The Bright Building is home to digital incubation hub Mi-IDEA.  A collaboration between MSP and leading technology company Cisco, Mi-IDEA is an innovation centre to support start-ups to scale and to provide a space for co-innovation in the region. The building is also the centre of operations and demonstrator for CityVerve: Innovate UK’s Internet of Things city demonstrator, in which MSP is a lead partner.


 In 2018, MSP will launch a new digital tech incubator at Manchester Technology Centre,  part of Circle Square. This will support start-ups and tech entrepreneurs focused on data science and technology innovation.


 Working with Bruntwood as the strategic property partner, MSP in a joint venture with MFT has secured planning permission for Citylabs 2.0 & 3.0.  A £60m, 220,000 sq ft extension to the Citylabs campus which will see the creation of a world-leading precision medicine and data analytical hub due to open in 2020.